qDSA Blood Flow Measurement in Patients Undergoing TAE of the Liver

Recruiting now · Not applicable

Conditions studied: Transarterial Embolism, Transarterial Chemoembolization, Radioembolization

In brief

The purpose of this research is to evaluate a new technique, quantitative digital subtraction angiography (qDSA), to measure blood flow during liver embolization procedures. Liver embolization is a way of treating liver tumors by blocking blood flow to it. The qDSA technique could help doctors ensure the blood flow to the tumor is decreased by the right amount by calculating blood flow before, during, and after the procedure. Up to 20 participants will be enrolled for 1 study visit and data collection for up to 6 months.

Key facts

Study ID

NCT06971991

Run by

University of Wisconsin, Madison

People needed

20

Starts

2025-03-13

Expected to finish

2026-12-01

Last updated by the study team

2026-03-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Give voluntary, written informed consent to participate in this study and willing to comply with study-related evaluation and procedure schedule

You may not qualify if…

• Pregnancy or breastfeeding
• Patients with an acute kidney injury or stage IV or V chronic kidney disease (Cr greater than 2.4 or estimated glomerular filtration rate (eGFR) less than 30), unless anuric and on dialysis without expected return of renal function.
• Patients with an iodinated contrast allergy who cannot be adequately premedicated to receive contrast as part of the embolization procedure.
• Patients with a physical or psychological condition that would impair study participation.
• The patient is judged unsuitable for study participation by the Investigator for any other reason

Where it is running

• UW Hospital and Clinics — Madison, Wisconsin, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.